Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
批准号:
8431428
负责人:
Daisy Sahoo
金额:
$35.81万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-01 至 2015-02-28
关键词:
AmericanApolipoprotein A-IAtherosclerosisBindingBiotinylationCD36 geneCell membraneCellsChimera organismCholesterolCholesterol EstersCholesterol HomeostasisComplexCoupledCysteineDataExcisionExtracellular DomainFluorescenceFluorescence Resonance Energy TransferFourier transform ion cyclotron resonanceGoalsGrantHeart DiseasesHepaticHigh Density Lipoprotein CholesterolHigh Density LipoproteinsHydrolysisKnockout MiceLaboratoriesLeadLifeLigand BindingLigandsLinkLipidsLipoprotein BindingLiverMalignant NeoplasmsMapsMass Spectrum AnalysisMeasuresMediatingMethodsMolecularMolecular ConformationMonitorMutationPathologyPatternPeptide MappingPeptidesPhysiologicalPlasmaPreventionPropertyProteinsProtocols documentationResearchRoleSR-BI receptorSeriesSiteSite-Directed MutagenesisSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationSpectrum AnalysisStrokeTestingTryptophanVariantWorkadenoviral-mediatedbasecardiovascular disorder preventioncrosslinkdesigndimerdisulfide bondextracellularhigh density lipoprotein receptorhypercholesterolemiaimprovedin vivoinsightkillingsmonomermutantnovel therapeuticspreventpublic health relevancereceptorresearch studyreverse cholesterol transportscavenger receptoruptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The class type I scavenger receptor (SR-BI) is the high density lipoprotein (HDL) receptor that regulates HDL- cholesterol metabolism and is directly linked to the ability of HDL to be athero-protective. The long-term objective of our research is to understand the function of SR-BI in the delivery of cholesteryl ester (CE) from HDL to the liver for cholesterol disposal. New insight into how SR-BI mediates the efficiency of HDL-CE delivery is key to developing methods for prevention of cardiovascular disease. This proposal consists of three primary objectives that will evaluate how the structural organization of SR-BI at the plasma membrane and the proper alignment of SR-BI with HDL mediate enhanced cholesterol flux to the liver. Aim 1 will determine the physiological organization and relevance of the SR-BI oligomer in vivo. Goal 1 will use bimolecular fluorescence complementation coupled with fluorescence resonance energy transfer spectroscopy to confirm the presence of SR-BI oligomers in live cells and monitor changes in oligomer formation upon ligand engagement. In Goal 2, the physiological relevance of SR-BI oligomerization in reverse cholesterol transport will be assessed following adenoviral-mediated expression of oligomerization-defective mutant SR-BI receptors in SR-BI knock-out mice. Aim 2 is designed to examine the molecular determinants for "productive complex" formation (i.e. proper alignment) between HDL and SR-BI that promote selective uptake of HDL-CE. In Goal 1, a series of SR-BI/CD36 chimeras will be designed to identify regions within the extracellular domain of SR-BI that are crucial for HDL-CE selective uptake and vital for "productive complex" formation. In Goal 2, the combination of site-specific ligand-directed crosslinking and mass spectrometry will be used to map sites of interaction between SR-BI and HDL. Aim 3 will explore how the conformation of the extracellular domain of SR-BI impacts lipid transfer from HDL to the plasma membrane. Goal 1 will use tryptophan quenching to test the hypothesis that hydrophobic regions of SR-BI are required to interact with the plasma membrane and/or ligand to facilitate efficient lipid transfer and cholesterol flux. Goal 2 will determine the role of extracellular cysteine residues in SR-BI function and experiments are designed to identify intra- and intermolecular disulfide bonding patterns. Together, these studies will improve our understanding of how SR-BI mediates the efficiency of HDL-CE selective uptake and will shed new insights into cholesterol metabolism and protection against atherosclerosis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport
-
批准号:9914074
-
项目类别:
-
资助金额:$69.06万
-
财政年份:2018
-
负责人:Daisy Sahoo
-
依托单位:
SR-BI and PCPE2: Novel partners in bi-directional cholesterol transport
-
批准号:10153867
-
项目类别:
-
资助金额:$69.06万
-
财政年份:2018
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:8625808
-
项目类别:
-
资助金额:$36.87万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective uptake and hydrolysis of cholesteryl ester by SR-BI
-
批准号:7227105
-
项目类别:
-
资助金额:$36.78万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:9128733
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective uptake and hydrolysis of cholesteryl ester by SR-BI
-
批准号:7097685
-
项目类别:
-
资助金额:$38.69万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective uptake and hydrolysis of cholesteryl ester by SR-BI
-
批准号:7391163
-
项目类别:
-
资助金额:$36.78万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:10375464
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:8052855
-
项目类别:
-
资助金额:$38.0万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:9300994
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:10595047
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective uptake and hydrolysis of cholesteryl ester by SR-BI
-
批准号:7595068
-
项目类别:
-
资助金额:$36.78万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:7884758
-
项目类别:
-
资助金额:$38.0万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
Selective Uptake and Hydrolysis of Cholesteryl Ester by SR-BI
-
批准号:8220873
-
项目类别:
-
资助金额:$37.62万
-
财政年份:1997
-
负责人:Daisy Sahoo
-
依托单位:
海外基金